Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells

B Dinesh Kumar; K Krishnakumar; Saravana Kumar Jaganathan; Mahitosh Mandal

Articles

Abstract

Pharmacognosy Magazine,2013,9,33,72-75.

DOI:10.4103/0973-1296.108145

Published:March 2013

Type:Original Article

Authors:

Author(s) affiliations:

B Dinesh Kumar¹, K Krishnakumar², Saravana Kumar Jaganathan³, Mahitosh Mandal⁴
¹Department of Pharmaceutics, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala, India
²Department of Chemistry, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala, India
³Department of Research and Development, PSNA College of Engineering and Technology, Dindigul, Tamil Nadu, India
⁴School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India

Abstract:

Background: Stem barks of Mangifera indica contain a rich content of mangiferin (xanthone glucoside), whereas Murraya koenigii leaves contain rich sources of mahanimbine (carbazole alkaloid) and used traditionally for the treatment of diabetes. Objective: To investigate the effects of mangiferin (xanthone glucoside) and mahanimbine (carbazole alkaloid) on glucose utilization in 3T3-L1 cells. Materials and Methods: Mangiferin was isolated from stem barks of Mangifera indica and mahanimbine was isolated from Murraya koenigii leaves. These isolated compounds were subjected to MTT assay and glucose utilization test with 3T3-L1 cells. Results: Treatment of the 3T3-L1 cells with mangiferin and mahanimbine increased the glucose utilization in a dose-dependent manner. At a concentration of 1 mM, mangniferin showed 2-fold increase in glucose utilization compared with untreated control. In case of mahanimbine, the observed effect at 1 mM was almost equivalent to positive control (insulin at 1 μM). Moreover, MTT assay showed that both of these compounds were less toxic at a concentration of 1 mM (nearly 75% cells are viable). Conclusion: The present results indicated that these natural products (mangiferin and mahanimbine) exhibited potential ethnomedical uses in management of diabetes.